Stock listing
Oncolys Biopharma, Inc.
Selected listing: 4588 · TSE · JPY · JP
Oncolys Biopharma, Inc. (Tokyo:4588), Health Technology. Latest release Aug 7, 2026: Non-consolidated Financial Results for the Six Months Ended June 30, 2026…
- Ticker
- Tokyo:4588
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Tokyo
- Currency
- JPY
About Oncolys Biopharma, Inc.
Oncolys Biopharma, Inc. is a public company listed under the ticker 4588 in the Japanese market. Oncolys focuses on developing innovative biopharmaceuticals to address unmet medical needs.
Latest news from Oncolys Biopharma, Inc.
Non-consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]
August 7, 2026
Oncolys BioPharma Announces Full Marketing Approval in Japan for Telomelysin for the Treatment of Esophageal Cancer
June 8, 2026
Oncolys BioPharma : Non-consolidated Financial Results for the Three Months Ended March 31, 2026
May 8, 2026
Oncolys BioPharma : Non-consolidated Financial Results for the Fiscal Year Ended December 31, 2025
February 8, 2026
Oncolys BioPharma : Non-consolidated Financial Results for the Nine Months Ended September 30, 2025
November 7, 2025
Research Oncolys Biopharma, Inc.
Oncolys Biopharma, Inc. company profile
View the public company page for Oncolys Biopharma, Inc. on 6ix.
Oncolys Biopharma, Inc. news
Read company news and market updates connected to Oncolys Biopharma, Inc..
Oncolys Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Oncolys Biopharma, Inc..